Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: A systematic review and meta-analysis of randomized controlled trials

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 3, 2015, Pages 198-206

  Zhang, Y Q ^a,b   Zhu, D ^a   Zhou, X Y ^a,b   Liu, Y Y ^a,b   Qin, B ^a,b   Ren, G P ^a,b   Xie, P ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Randomized controlled trials; Repetitive transcranial magnetic stimulation; Treatment resistant depression

Indexed keywords

ARTICLE; COMPARATIVE STUDY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RISK FACTOR; SHAM PROCEDURE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; PROCEDURES;

DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84924911707     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144270     Document Type: Article

References (44)

1. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012; 379: 1045-1055, doi: 10.1016/S0140-6736(11)60602-8.
2. World Health Organization. The global burden of disease: 2004 Update. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed March 8, 2013.
3. Bschor T. Therapy-resistant depression. Expert Rev Neurother 2010; 10: 77-86, doi: 10.1586/ern.09.137.
4. Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence 2012; 6: 369-388, doi: 10.2147/PPA.S29716.
5. Blier P, Keller MB, Pollack MH, Thase ME, Zajecka JM, Dunner DL. Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry 2007; 68: e06, doi: 10.4088/JCP.0307e06.
6. Brunoni AR, Fregni F. Clinical trial design in non-invasive brain stimulation psychiatric research. Int J Methods Psychiatr Res 2011; 20: e19-e30, doi: 10.1002/mpr.338.
7. Kozel FA, George MS. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract 2002; 8: 270-275, doi: 10.1097/00131746-200209000-00003.
8. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009; 39: 65-75, doi: 10.1017/S0033291708003462.
9. Dell’osso B, Camuri G, Castellano F, Vecchi V, Benedetti M, Bortolussi S, et al. Meta-review of metanalytic studies with repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depression. Clin Pract Epidemiol Ment Health 2011; 7: 167-177, doi: 10.2174/1745017901107010167.
10. Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013; 38: 543-551, doi: 10.1038/npp.2012.237.
11. Drevets WC. Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 2007; 1121: 499-527, doi: 10.1196/annals.1401.029.
12. Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008; 63: 369-376, doi: 10.1016/j.biopsych.2007.05.033.
13. Speer AM, Benson BE, Kimbrell TK, Wassermann EM, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. J Affect Disord 2009; 115: 386-394, doi: 10.1016/j.jad.2008.10.006.
14. Speer AM, Kimbrell TA, Wassermann EM, Repella D, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000; 48: 1133-1141, doi: 10.1016/S0006-3223(00)01065-9.
15. Fierro B, Brighina F, Vitello G, Piazza A, Scalia S, Giglia G, et al. Modulatory effects of low-and high-frequency repetitive transcranial magnetic stimulation on visual cortex of healthy subjects undergoing light deprivation. J Physiol 2005; 565: 659-665, doi: 10.1113/jphysiol.2004.080184.
16. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet 2006; 367: 153-167, doi: 10.1016/S0140-6736(06)67964-6.
17. Blumberger DM, Mulsant BH, Fitzgerald PB, Rajji TK, Ravindran AV, Young LT, et al. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatmentresistant major depression. World J Biol Psychiatry 2012; 13: 423-435, doi: 10.3109/15622975.2011.579163.
18. Fitzgerald PB, Hoy KE, Herring SE, McQueen S, Peachey AV, Segrave RA, et al. A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. J Affect Disord 2012; 139: 193-198, doi: 10.1016/j.jad.2012.02.017.
19. Berlim MT, Van den Eynde F, Daskalakis ZJ. A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression. Psychol Med 2013; 43: 2245-2254, doi: 10.1017/S0033291712002802.
20. Zheng P, Wang Y, Chen L, Yang D, Meng H, Zhou D, et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteomics 2013; 12: 207-214, doi: 10.1074/mcp.M112.021816.
21. Thase ME, Rush AJ. Treatment resistant depression. In: Bloom FE, Kupfer DJ (Editors), Psychopharmacology: The fourth generation of progress. New York: Raven Press Ltd.; 1995. p 1081-1097.
22. Hefner J, Ashton AK, D’Mello DA, Dantz B, Leon FG, Matson GA, et al. Response to treatment: gaining and maintaining remission from depression. J Fam Pract 2003; Suppl: S61-S62.
23. Riedel M, Moller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, et al. Response and remission criteria in major depression -a validation of current practice. J Psychiatr Res 2010; 44: 1063-1068, doi: 10.1016/j.jpsychires.2010.03.006.
24. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaanalysis. Lancet 2009; 373: 746-758, doi: 10.1016/S0140-6736(09)60046-5.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560, doi: 10.1136/bmj.327.7414.557.
26. Zhou X, Chen J, Li Q, Ren G, Yao G, Liu M, et al. Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke 2012; 43: 2923-2930, doi: 10.1161/STROKEAHA.112.667535.
27. Conca A, Di Pauli J, Beraus W, Hausmann A, Peschina W, Schneider H, et al. Combining high and low frequencies in rTMS antidepressive treatment: preliminary results. Hum Psychopharmacol 2002; 17: 353-356, doi: 10.1002/hup.422.
28. Loo CK, Mitchell PB, Croker VM, Malhi GS, Wen W, Gandevia SC, et al. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychol Med 2003; 33: 33-40.
29. Rybak M, Bruno R, Turnier-Shea Y, Pridmore S. An attempt to increase the rate and magnitude of the antidepressant effect of transcranial magnetic stimulation (TMS). Ger J Psych 2005; 8: 59-65.
30. Fitzgerald PB, Benitez J, De Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006; 163: 88-94, doi: 10.1176/appi.ajp.163.1.88.
31. Garcia-Toro M, Salva J, Daumal J, Andres J, Romera M, Lafau O, et al. High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res 2006; 146: 53-57, doi: 10.1016/j.pscychresns.2004.08.005.
32. McDonald WM, Easley K, Byrd EH, Holtzheimer P, Tuohy S, Woodard JL, et al. Combination rapid transcranial magnetic stimulation in treatment refractory depression. Neuropsychiatr Dis Treat 2006; 2: 85-94.
33. Pallanti S, Bernardi S, Di Rollo A, Antonini S, Quercioli L. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience 2010; 167: 323-328, doi: 10.1016/j.neuroscience.2010.01.063.
34. Fitzgerald PB, Hoy K, Gunewardene R, Slack C, Ibrahim S, Bailey M, et al. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression. Psychol Med 2011; 41: 1187-1196, doi: 10.1017/S0033291710001923.
35. Lam RW, Chan P, Wilkins-Ho M, Yatham LN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 2008; 53: 621-631.
36. George MS. Transcranial magnetic stimulation for the treatment of depression. Expert Rev Neurother 2010; 10: 1761-1772, doi: 10.1586/ern.10.95.
37. Padberg F, Zwanzger P, Keck ME, Kathmann N, Mikhaiel P, Ella R, et al. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology 2002; 27: 638-645, doi: 10.1016/S0893-133X(02)00355-X.
38. Okada F, Takahashi N, Tokumitsu Y. Dominance of the ‘nondominant’ hemisphere in depression. J Affect Disord 1996; 37: 13-21, doi: 10.1016/0165-0327(95)00040-2.
39. Nahas Z, Lomarev M, Roberts DR, Shastri A, Lorberbaum JP, Teneback C, et al. Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI. Biol Psychiatry 2001; 50: 712-720, doi: 10.1016/S0006-3223(01)01199-4.
40. Berlim MT, Van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following highfrequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and metaanalysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014; 44: 225-239, doi: 10.1017/S0033291713000512.
41. Berlim MT, Van den Eynde F, Daskalakis ZJ. Highfrequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry 2013; 74: e122-e129, doi: 10.4088/JCP.12r07996.
42. Berlim MT, Van den Eynde F, Daskalakis ZJ. Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and metaanalysis of randomized trials. Depress Anxiety 2013; 30: 614-623, doi: 10.1002/da.22060.
43. Silber S. A new and rapid scoring system to assess the scientific evidence from clinical trials. J Interv Cardiol 2006; 19: 485-492, doi: 10.1111/j.1540-8183.2006.00205.x.
44. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser 2004; 4: 1-98.